HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trypanosoma brucei rhodesiense infection in vervet monkeys. II. Provocation of the encephalitic late phase by treatment of infected monkeys.

Abstract
Four out of 8 monkeys infected with Trypanosoma rhodesiense and treated with trypanocidal drugs at various intervals after infection (days 55-58, days 62-65, day 68) developed encephalitis. In 2 of these animals, killed 2 weeks after treatment, the encephalitis presenting was incipient; the other 2 monkeys died as a result of severe encephalitis a little more than 2 and 3 months after treatment, respectively. At the time of treatment, the animals revealed a parasitization of the CSF, but there were no clinical or neurological signs of any involvement of the central nervous system. The observations confirm observations made in human trypanosomiasis, and in experiments on rodents, which indicate that the encephalitic late phase may result from inadequate treatment. These observations may indicate that the encephalitis of the late phase may be methodologically provoked by infection and subliminal treatment after parasitization of the CSF, and that this procedure may be more promising of success than the method of infection only, as a method for the production of an animal model of the encephalitic late phase.
AuthorsH Schmidt, P Sayer
JournalTropenmedizin und Parasitologie (Tropenmed Parasitol) Vol. 33 Issue 4 Pg. 255-9 (Dec 1982) ISSN: 0303-4208 [Print] Germany
PMID7164167 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Trypanocidal Agents
Topics
  • Animals
  • Cercopithecus
  • Encephalitis (etiology, pathology)
  • Recurrence
  • Trypanocidal Agents (therapeutic use)
  • Trypanosoma brucei brucei
  • Trypanosomiasis, African (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: